0001493152-24-025105.txt : 20240625
0001493152-24-025105.hdr.sgml : 20240625
20240625163247
ACCESSION NUMBER: 0001493152-24-025105
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240621
FILED AS OF DATE: 20240625
DATE AS OF CHANGE: 20240625
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Gurrola Sandra M
CENTRAL INDEX KEY: 0001618457
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-11460
FILM NUMBER: 241069365
MAIL ADDRESS:
STREET 1: 2231 RUTHERFORD ROAD
STREET 2: SUITE 200
CITY: CARLSBAD
STATE: CA
ZIP: 92008
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Eterna Therapeutics Inc.
CENTRAL INDEX KEY: 0000748592
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 311103425
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1035 CAMBRIDGE STREET
STREET 2: SUITE 18A
CITY: CAMBRIDGE
STATE: MA
ZIP: 02141
BUSINESS PHONE: (212) 582-1199
MAIL ADDRESS:
STREET 1: 10531 4S COMMONS DRIVE
STREET 2: SUITE 166-550
CITY: SAN DIEGO
STATE: CA
ZIP: 92127
FORMER COMPANY:
FORMER CONFORMED NAME: Brooklyn ImmunoTherapeutics, Inc.
DATE OF NAME CHANGE: 20210325
FORMER COMPANY:
FORMER CONFORMED NAME: NTN BUZZTIME INC
DATE OF NAME CHANGE: 20051230
FORMER COMPANY:
FORMER CONFORMED NAME: NTN COMMUNICATIONS INC
DATE OF NAME CHANGE: 19920703
4
1
ownership.xml
X0508
4
2024-06-21
0
0000748592
Eterna Therapeutics Inc.
ERNA
0001618457
Gurrola Sandra M
C/O ETERNA THERAPEUTICS INC.
1035 CAMBRIDGE STREET, SUITE 18A
CAMBRIDGE
MA
02141
0
1
0
0
Sr. VP of Finance
0
Common Stock
2024-06-21
4
M
0
437
A
1365
D
Common Stock
2024-06-21
4
F
0
180
1.94
D
1185
D
Restricted Stock Units
2024-06-21
4
M
0
437
0
D
Common Stock
437
437
D
Each restricted stock unit converts into one share of common stock.
On June 21, 2021, the reporting person was granted 1,750 restricted stock units, vesting in four substantially equal installments beginning on the first anniversary of the grant date.
/s/ Sandra Gurrola
2024-06-25